Friday, July 23, 2010

Despite the crisis, biotechnology and pharmaceuticals received a record U.S. investment

In 2008, the pharmaceutical and biotechnology companies of the United States spent a record amount on research - $ 65.2 billion, a $ 2 billion more than in 2007.
These data provide marketing firm Burrill & Company.
Of these funds, approximately $ 50.3 billion accounted for pharmaceutical, about $ 14.9 billion - biotech companies.

Investigation of Wharton Business School found that in 2006 U.S. companies operating in this market, spending on scientific research and introduction of scientific developments in the production of $ 65 thousand to each of its employees. This is about 8 times more than the level of such investments of all other sectors of the U.S. economy
In general, according to the Association of Developers and  pharmaceutical manufacturers USA, during the tests are more than 2,9 thousand new medicines. Of these, about 750 are designed to fight cancer, more than 300 - with cardiovascular disease, 150 - diabetes, roughly 110 - VI \ AIDS.

Recall that in Ukraine for the financing of the national program for prevention of HIV infection for 2009-2013, approved recently by President Viktor Yushchenko, must be more than 3,6 billion UAH. Of these, 2.9 billion USD is planned to allocate from the state budget, USD 267.3 million - from the local budgets. Another 478.5 million USD is expected to draw from other sources. In addition, the program declares support for domestic pharmacists.

No comments:

Post a Comment